Monument Capital Management Purchases New Shares in iShares Biotechnology ETF $IBB

Monument Capital Management bought a new position in iShares Biotechnology ETF (NASDAQ:IBB) during the third quarter, according to its most recent disclosure with the SEC. The firm bought 28,887 shares of the financial services provider’s stock, valued at approximately $6,081,000. iShares Biotechnology ETF accounts for about 1.3% of Monument Capital Management’s investment portfolio, making the stock its 14th biggest holding. Monument Capital Management owned approximately 0.06% of iShares Biotechnology ETF at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. CoreCap Advisors LLC increased its stake in shares of iShares Biotechnology ETF by 21.5% in the third quarter. CoreCap Advisors LLC now owns 2,277 shares of the financial services provider’s stock worth $479,000 after purchasing an additional 403 shares in the last quarter. Valeo Financial Advisors LLC boosted its holdings in iShares Biotechnology ETF by 10.4% in the 3rd quarter. Valeo Financial Advisors LLC now owns 1,818 shares of the financial services provider’s stock worth $383,000 after buying an additional 172 shares during the period. Kaydan Wealth Management Inc. boosted its holdings in iShares Biotechnology ETF by 3.9% in the 3rd quarter. Kaydan Wealth Management Inc. now owns 1,363 shares of the financial services provider’s stock worth $287,000 after buying an additional 51 shares during the period. Toth Financial Advisory Corp increased its stake in iShares Biotechnology ETF by 2.1% in the 3rd quarter. Toth Financial Advisory Corp now owns 43,129 shares of the financial services provider’s stock worth $9,080,000 after buying an additional 868 shares in the last quarter. Finally, Whalen Wealth Management Inc. bought a new stake in iShares Biotechnology ETF during the third quarter valued at about $229,000. Institutional investors own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Down 1.4%

Shares of IBB opened at $200.48 on Friday. iShares Biotechnology ETF has a 1 year low of $149.09 and a 1 year high of $217.12. The company has a 50 day simple moving average of $205.40 and a two-hundred day simple moving average of $186.32.

iShares Biotechnology ETF Cuts Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, September 18th. Shareholders of record on Tuesday, September 15th were issued a $0.0112 dividend. The ex-dividend date was Tuesday, September 15th. This represents a $0.04 dividend on an annualized basis and a yield of 0.0%. This is a decrease from iShares Biotechnology ETF’s previous quarterly dividend of $0.0238.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.